D. W. Brighty

发表

Candidate Polyanionic Microbicides Inhibit Human T-Cell Lymphotropic Virus Type 1 Receptor Interactions, Cell-Free Infection, and Cell-Cell Spread

Q. Sattentau, D. Romer, D. W. Brighty, 2008, Antimicrobial Agents and Chemotherapy.

Conformation-Specific Antibodies Targeting the Trimer-of-Hairpins Motif of the Human T-Cell Leukemia Virus Type 1 Transmembrane Glycoprotein Recognize the Viral Envelope but Fail To Neutralize Viral Entry

J. Woof, K. Nurkiyanova, D. W. Brighty, 2007, Journal of Virology.

Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells.

A. Leigh-Brown, M. Lairmore, D. W. Brighty, 2001, Virus research.

Nonhelical Leash and α-Helical Structures Determine the Potency of a Peptide Antagonist of Human T-Cell Leukemia Virus Entry

D. W. Brighty, Antonis Mirsaliotis, Daniel Lamb, 2008, Journal of Virology.

Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope

A. W. Schüttelkopf, D. V. van Aalten, D. W. Brighty, 2008, Retrovirology.

Basic Residues Are Critical to the Activity of Peptide Inhibitors of Human T Cell Leukemia Virus Type 1 Entry*

S. Kelly, D. W. Brighty, Antonis Mirsaliotis, 2009, Journal of Biological Chemistry.

Viral interference with host mRNA surveillance, the nonsense-mediated mRNA decay (NMD) pathway, through a new function of HTLV-1 Rex: implications for retroviral replication.

K. Nakano, Yuetsu Tanaka, Toshiki Watanabe, 2013, Microbes and infection.

Phenotypic analysis of human immunodeficiency virus type 1 Rev trimerization-interface mutants in human cells.

D. W. Brighty, Roochi Trikha, 2005, The Journal of general virology.

Charge-Surrounded Pockets and Electrostatic Interactions with Small Ions Modulate the Activity of Retroviral Fusion Proteins

A. W. Schüttelkopf, D. V. van Aalten, D. W. Brighty, 2011, PLoS pathogens.

An antibody that blocks human T-cell leukemia virus type 1 six-helix-bundle formation in vitro identified by a novel assay for inhibitors of envelope function.

K. Nurkiyanova, D. W. Brighty, Antonis Mirsaliotis, 2007, The Journal of general virology.

Human T-Cell Leukemia Virus Type 1 Receptor Expression among Syncytium-Resistant Cell Lines Revealed by a Novel Surface Glycoprotein-Immunoadhesin

D. W. Brighty, S. R. Jassal, Richard G. Pöhler, 2001, Journal of Virology.

Human T-Cell Leukemia Virus Type 1 Envelope Glycoprotein gp46 Interacts with Cell Surface Heparan Sulfate Proteoglycans

Q. Sattentau, J. Weber, P. Klasse, 2003, Journal of Virology.

The human immunodeficiency virus LTR-promoter region as a reporter of stress-induced gene expression.

D. W. Brighty, S. R. Jassal, M. Bate, 2000, Methods in molecular biology.

A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals.

M. Rosenberg, D. W. Brighty, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo

F. Martin, G. Taylor, B. Galvão-Castro, 2016, Viruses.

Antibodies to the Envelope Glycoprotein of Human T Cell Leukemia Virus Type 1 Robustly Activate Cell-Mediated Cytotoxic Responses and Directly Neutralize Viral Infectivity at Multiple Steps of the Entry Process

D. W. Brighty, Antonis Mirsaliotis, Chien-Wen S Kuo, 2011, The Journal of Immunology.

ProcessInfectivity at Multiple Steps of the Entry Responses and Directly Neutralize Viral Robustly Activate Cell-Mediated Cytotoxic Human T Cell Leukemia Virus Type 1 Antibodies to the Envelope Glycoprotein of

D. W. Brighty, Antonis Mirsaliotis, Chien-Wen S Kuo, 2011 .

An Antiviral Peptide Targets a Coiled-Coil Domain of the Human T-Cell Leukemia Virus Envelope Glycoprotein

N. C. Price, S. Kelly, D. W. Brighty, 2003, Journal of Virology.

The Synthetic Peptide P-197 Inhibits Human T-Cell Leukemia Virus Type 1 Envelope-Mediated Syncytium Formation by a Mechanism That Is Independent of Hsc70

D. W. Brighty, S. R. Jassal, 2001, Journal of Virology.

A Leptomycin B-sensitive Homologue of Human CRM1 Promotes Nuclear Export of Nuclear Export Sequence-containing Proteins inDrosophila Cells*

R. Saunders, M. Rosenberg, Milo B. Fasken, 2000, The Journal of Biological Chemistry.

Resistance to Neutralization by Antibodies Targeting the Coiled Coil of Fusion-active Envelope Is a Common Feature of Retroviruses*

K. Nurkiyanova, D. W. Brighty, Antonis Mirsaliotis, 2007, Journal of Biological Chemistry.

Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.

I. Chen, M. Rosenberg, M. Ivey-Hoyle, 1991, Proceedings of the National Academy of Sciences of the United States of America.

The rev-responsive element negatively regulates human immunodeficiency virus type 1 env mRNA expression in primate cells

M. Churchill, M. Rosenberg, M. J. Churchill, 1996, Journal of virology.